Deficiency of the anticoagulant annexin A5 attenuates atherosclerotic plaque development in ApoE-/- mice

被引：0
|
作者：
Kusters, D. [1 ]
Chatrou, M. L. L. [1 ]
Willems, B. A. G. [1 ]
Schutters, K. [2 ]
Schurgers, L. J. [1 ]
Reutelingsperger, C. P. M. [1 ]
机构：
[1] Maastricht Univ, Maastricht, Netherlands
[2] Univ Aachen, Aachen, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [41] Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE-/- Mice: Molecular Imaging with 14C-FDG and 99mTc-Annexin A5
    Zhao, Yan
    Watanabe, Ayahisa
    Zhao, Songji
    Kobayashi, Tatsuo
    Fukao, Keita
    Tanaka, Yoshikazu
    Nakano, Toru
    Yoshida, Tetsuya
    Takemoto, Hiroshi
    Tamaki, Nagara
    Kuge, Yuji
    PLOS ONE, 2014, 9 (02):
  • [42] Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of Apoe-/- Mice: Molecular Imaging with 14C-FDG and 99mTc-annexin A5
    Zhao, Yan
    Zhao, Songji
    Kuge, Yuji
    Watanabe, Ayahisa
    Fukao, Keita
    Tanaka, Yoshikazu
    Nakano, Toru
    Takemoto, Hiroshi
    Tamaki, Nagara
    CIRCULATION, 2011, 124 (21)
  • [43] CD40 Targeted Imaging of Atherosclerotic Plaque Lesions in ApoE-/- Mice
    Grafe, Michael
    Dietrich, Thore
    Stibenz, Dietger
    Klohs, Jan
    Wunder, Andreas
    Lutgens, Esther
    Daemen, Mat
    Fleck, Eckart
    Graf, Kristof
    CIRCULATION, 2008, 118 (18) : S554 - S554
  • [44] Cordycepin stimulates autophagy in macrophages and prevents atherosclerotic plaque formation in ApoE-/- mice
    Li, Xin
    Zhou, Yue
    Zhang, Xue
    Cao, Xiaoxue
    Wu, Chongming
    Guo, Peng
    ONCOTARGET, 2017, 8 (55) : 94726 - 94737
  • [45] Systemic mast cell activation induces atherosclerotic plaque progression in ApoE-/- mice
    Bot, I.
    De Jager, S. C. A.
    Van Berkel, T. J. C.
    Biessen, E. A. L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 247 - 247
  • [46] Oral rapamycin attenuates progression of atherosclerotic plaque in ApoE knockout mice
    Pakala, R
    Burnett, MS
    Gulick, CP
    Fournadjiev, J
    Leborgne, L
    Cheneau, EF
    Hellinga, D
    Epstein, SE
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 239A - 239A
  • [47] LIGHT DEFICIENCY IN APOE-/- MICE AGGRAVATES ATHEROMA PLAQUE BY ENHANCING APOPTOSIS
    Hurtado-Genoves, Gema
    Herrero-Cervera, Andrea
    Vinue, Angela
    Martin-Vano, Susana
    Aguilar-Ballester, Maria
    Taberner-Cortes, Alida
    Jimenez-Marti, Elena
    Martinez-Hervas, Sergio
    Gonzalez-Navarro, Herminia
    ATHEROSCLEROSIS, 2024, 395
  • [48] Oral rapamycin attenuates atherosclerotic plaque progression in ApoE knockout mice
    Pakala, R
    Stabile, E
    Finegold, AA
    Hellinga, D
    Seabron, R
    Baffour, R
    Waksman, R
    CIRCULATION, 2004, 110 (17) : 53 - 53
  • [49] Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE-/- mice
    Chen, Jianghong
    Zhao, Li
    Sun, Dongdong
    Narsinh, Kazim
    Li, Chunhong
    Zhang, Zheng
    Qi, Shun
    Wei, Guangquan
    Li, Weijie
    Guo, Wenyi
    Cao, Feng
    INFLAMMATION RESEARCH, 2012, 61 (12) : 1299 - 1307
  • [50] Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice
    Shen, Linghong
    Sun, Zhe
    Nie, Peng
    Yuan, Ruosen
    Cai, Zhaohua
    Wu, Caizhe
    Hu, Liuhua
    Jin, Shuxuan
    Zhou, Hu
    Zhang, Xiaokun
    He, Ben
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (14) : 2559 - 2572
12345